Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 659 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Insulin Degludec: A Significant Advancement in Ultralong-Acting Basal Insulin
Sanjay Kalra
Diabetes Therapy.2013;4(2)167
[DOI]
2Insulin and value-added therapy
Sanjay Kalra,Yashdeep Gupta,Manash Baruah
Journal of Social Health and Diabetes.2014;02(02)059
[DOI]
3Structural and Functional Study of the GlnB22-Insulin Mutant Responsible for Maturity-Onset Diabetes of the Young
Kvetoslava Krížková,Václav Veverka,Lenka Maletínská,Rozálie Hexnerová,Andrzej M. Brzozowski,Jirí Jirácek,Lenka Žáková,Vladimir N. Uversky
PLoS ONE.2014;9(11)e112883
[DOI]
4Injectable Coformulations in Diabetology
Sanjay Kalra,Yashdeep Gupta
Diabetes Therapy.2015;6(2)101
[DOI]
5Antihyperglycemic Medications
Karen Beer
Physician Assistant Clinics.2017;2(1)25
[DOI]
6Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open-label, cross-over study using continuous glucose monitoring profiles
Yuji Kawaguchi,Jun Sawa,Noriko Sakuma,Yasuro Kumeda
Journal of Diabetes Investigation.2019;10(2)343
[DOI]
7The Future of Basal Insulin
Viral N. Shah,Emily G. Moser,Aaron Blau,Megha Dhingra,Satish K. Garg
Diabetes Technology & Therapeutics.2013;15(9)727
[DOI]
8Improving adherence to insulin: Hope with degludec
Sanjay Kalra,A Unnikrishnan,A Das
Journal of Social Health and Diabetes.2014;02(01)001
[DOI]
9Nueva insulina basal de acción ultralenta: insulina degludec
Rafael Simó
Avances en Diabetología.2013;29(1)4
[DOI]
10Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement
Sanjay Kalra,ZafarA Latif,Abdurrahman Comlekci,GuillermoGonzalez Galvez,Rached Malik,MdFaruque Pathan,Ajay Kumar
Indian Journal of Endocrinology and Metabolism.2016;20(4)542
[DOI]
11Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec
Yuji Kawaguchi,Jun Sawa,Chie Hamai,Yasuro Kumeda
Diabetes Therapy.2019;10(4)1535
[DOI]
12RSSDI consensus recommendations on insulin therapy in the management of diabetes
R. Chawla,B. M. Makkar,S. Aggarwal,S. Bajaj,A. K. Das,S. Ghosh,A. Gupta,S. Gupta,S. Jaggi,J. Jana,J. Keswadev,S. Kalra,P. Keswani,V. Kumar,A. Maheshwari,A. Moses,C. L. Nawal,J. Panda,V. Panikar,G. D. Ramchandani,P. V. Rao,B. Saboo,R. Sahay,K. R. Setty,V. Viswanathan,SR Aravind,S Banarjee,A Bhansali,HB Chandalia,S Das,OP Gupta,S Joshi,A Kumar,KM Kumar,SV Madhu,A Mittal,V Mohan,C Munichhoodappa,A Ramachandran,BK Sahay,J Sai,V Seshiah,AH Zargar
International Journal of Diabetes in Developing Countries.2019;39(S2)43
[DOI]
13Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal–bolus therapy)
Yuji Kawaguchi,Jun Sawa,Chie Hamai,Yuri Nishimura,Yasuro Kumeda
Journal of Diabetes Investigation.2019;10(6)1527
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal